Credit: NIHR Sheffield Biomedical Research Center The Food and Drug Administration (FDA) in the U.S. has authorized the first approved drug for a rare form of motor neuron disease (MND) based on the results of a Phase 3 clinical trial completed at the University of Sheffield, the U.K. center for the international trial. Results from […]